RNS Number : 7073S
HeiQ PLC
08 November 2023
 

08 November 2023

 

HeiQ Plc

("HeiQ" or "the Company")

 

Notice of General Meeting to approve the annual report and related matters

 

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, announces that it will hold a General Meeting to approve the annual report and related matters at 12pm on Friday 1 December 2023 at the offices of Cavendish at One Bartholomew Close, London, EC1A 7BL.

The General Meeting will be held as a hybrid meeting, which means shareholders can attend online or in person. Details regarding how to attend virtually are set out below.

Shareholders attending the meeting online can watch, make comments and ask questions during the AGM via the online platform as follows:

Investors can sign up to Investor Meet Company for free and add to meet HEIQ PLC via:

https://www.investormeetcompany.com/heiq-plc/register-investor

The Company's Annual Report and Accounts for the year ended 31 December 2022 and the Notice of AGM are available to view on HeiQ's website, https://www.heiq.com/investor-relations. A copy of the Annual Report and Notice of AGM has also been submitted to the Financial Conduct Authority in the United Kingdom via the National Storage Mechanism and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies will be posted to shareholders, together with a form of proxy, today, 8 November 2023.

For further information, please contact:

 

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Cavendish Securities Plc (Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Tom Carnegie / Molly Gretton

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.

Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic 

We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.

We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGFFFLILLLDIIV